Buy Tata Consultancy Services Ltd & Ipca Laboratories Ltd

Buy Tata Consultancy Services Ltd & Ipca Laboratories Ltd

Tata Consultancy Services Ltd (TCS):

Tata Consultancy Services Ltd (TCS) has officially announced a consolidated sales of Rs. 39,946.00 Cr for the quarter ended on 31-03-2020, which is 0.23%, up from its previous quarter sales of Rs. 39,854.00 Cr and 5.0%, up from its previous year’s same quarter sales of Rs. 38,010.00 Cr. The firm has also announced its net profit after tax of Rs. 8,093.00 Cr in the most recent quarter.

Outlook:

Tata Consultancy Services Ltd (TCS) is a buy call with a target of Rs. 2,210.

Ipca Laboratories Ltd (IPCA):

Ipca Laboratories Ltd (IPCA) has officially announced a consolidated sales of Rs. 1,073.76 Cr for the quarter ended on 31-03-2020, which is -11.47%, down from its previous quarter sales of Rs. 1,212.86 Cr and 22.07%, up from its previous year’s same quarter sales of Rs. 879.61 Cr. The firm has also announced its net profit after tax of Rs. 85.38 Cr in the most recent quarter.

Outlook:

Ipca Laboratories Ltd (IPCA) is a buy call with a target of Rs. 1,774.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Related posts

Sell LIC Hsg Fin, Tata Power Future, NCC Future & ONGC Future

jabili

Buy Bajaj Finance & Radico Khaitan; Sell Adani Port and Special

ravi

Buy Titan, Central Depository Services & Speciality Restaurants

ravi